Evolution of circulating thyroid hormone levels in preterm infants during the first week of life: perinatal influences and impact on neurodevelopment
- 21 May 2019
- journal article
- research article
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 32 (6) , 597-606
Abstract
Background: For several decades, transient hypothyroxinemia of prematurity (THOP) has been a topic of debate. The pathophysiology is incompletely understood and consensus on the therapeutic approach is lacking. This study aimed at gaining a better insight into the pathogenesis by studying the trends in thyroid hormone (TH) levels during the first week of life. Methods: This single-center prospective observational study analyzed the plasma levels of total thyroxine (T4) and free thyroxine (fT4), total triiodothyronine (T3), thyroid-stimulating hormone (TSH) and T4-binding globulin (TBG) in cord blood and at the end of the first week of life in 120 preterm infants (gestational age [GA] <37 weeks). The change over time was calculated (delta, ∆). The impact of perinatal and subsequently postnatal variables on ∆ was studied by hierarchical multiple regression. The impact of ∆ on the neurodevelopmental outcome at the corrected ages of 9 and 24 months, measured by the Bayley Scales of Infant Development (BSID)-II, was assessed by logistic regression. Results: ∆fT4 levels were negatively affected by GA and use of dopamine, whereas only GA was associated with low ∆T3 levels. Negative ∆fT4 levels were present in 75% of the extremely low-for-gestational-age infants, whereas 23.5% had a negative ∆T3 level. There was an increased risk for an abnormal mental developmental score (<85) with decreasing ∆T3 at 9 months, corrected age, but not at 24 months. Conclusions: A negative evolution in circulating TH levels is principally an immaturity phenomenon, whereas dopamine can further suppress the hypothalamic-pituitary-thyroid axis. There is at least a temporary negative effect of this evolution on the infants’ neurodevelopment.Keywords
This publication has 26 references indexed in Scilit:
- An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks’ gestation: results of the TIPIT trialTrials, 2013
- Comparison of the Bayley II Mental Developmental Index and the Bayley III cognitive scale: are we measuring the same thing?Acta Paediatrica, 2011
- Phase 1 Trial of 4 Thyroid Hormone Regimens for Transient Hypothyroxinemia in Neonates of <28 Weeks' GestationPediatrics, 2009
- Postnatal thyroid hormones for preterm infants with transient hypothyroxinaemiaCochrane Database of Systematic Reviews, 2007
- Postnatal thyroid hormones for preterm infants with transient hypothyroxinaemia2006
- Ten-Year Follow-up of Children Born at <30 Weeks’ Gestational Age Supplemented With Thyroxine in the Neonatal Period in a Randomized, Controlled TrialPediatrics, 2005
- Dopamine infusion and hypothyroxinaemia in very low birth weight preterm infantsEuropean Journal of Pediatrics, 2003
- Effects of Thyroxine Supplementation on Neurologic Development in Infants Born at Less Than 30 Weeks' GestationNew England Journal of Medicine, 1997
- Extremely Low Doses of Heparin Release Lipase Activity into the Plasma and Can Thereby Cause Artifactual Elevations in the Serum-Free Thyroxine Concentration as Measured by Equilibrium DialysisThyroid®, 1996
- The CRIB (clinical risk index for babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care unitsThe Lancet, 1993